Cardioprotective activity of pongamia pinnata in streptozotocin-nicotinamide induced diabetic rats

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Badole, Sachin L ^a   Chaudhari, Swapnil M ^a   Jangam, Ganesh B ^a   Kandhare, Amit D ^b   Bodhankar, Subhash L ^b  

^a Affiliated to Savitribai Phule Pune University   (India)

^b BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE MB; GLUCOSE; LACTATE DEHYDROGENASE; PETROLEUM ETHER EXTRACT OF THE STEM BARK OF PONGAMIA PINNATA; PLANT EXTRACT; UNCLASSIFIED DRUG; ANTIOXIDANT; CARDIOTONIC AGENT; GLUCOSE BLOOD LEVEL; NICOTINAMIDE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HEART LEFT VENTRICLE CONTRACTION; HEART PROTECTION; HEART RATE; HEART VENTRICLE ENDDIASTOLIC PRESSURE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXIDATIVE STRESS; PONGAMIA PINNATA; QRS INTERVAL; QT INTERVAL; QTC INTERVAL; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; CHEMISTRY; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; HUMAN; MILLETTIA; PATHOLOGY;

PONGAMIA PINNATA; RATTUS;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; CARDIOTONIC AGENTS; DIABETES MELLITUS, EXPERIMENTAL; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MILLETTIA; NIACINAMIDE; OXIDATIVE STRESS; PLANT EXTRACTS; RATS; STREPTOZOCIN;

EID: 84928809009     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/403291     Document Type: Article

References (37)

1. L. Maya and F. J. Villarreal, "Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis, " Journal of Molecular and Cellular Cardiology, vol. 48, no. 3, pp. 524-529, 2010.
2. J. Wang, Y. Song, Q. Wang, P. M. Kralik, and P. N. Epstein, "Causes and characteristics of diabetic cardiomyopathy, " The Review of Diabetic Studies, vol. 3, no. 3, pp. 108-117, 2006.
3. Y. F. Zhi, J. B. Prins, and T. H. Marwick, "Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications, " Endocrine Reviews, vol. 25, no. 4, pp. 543-567, 2004.
4. W. B. Kannel, M. Hjortland, and W. P. Castelli, "Role of diabetes in congestive heart failure: the Framinghamstudy, " The American Journal of Cardiology, vol. 34, no. 1, pp. 29-34, 1974.
5. S. Boudina and E. D. Abel, "Diabetic cardiomyopathy revisited, " Circulation, vol. 115, no. 25, pp. 3213-3223, 2007.
6. M. Sulaiman, M. J. Matta, N. R. Sunderesan, M. P. Gupta, and M. Periasamy, "Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy, " American Journal of Physiology-Heart and Circulatory Physiology, vol. 298, no. 3, pp. H833-H843, 2010.
7. J. E. Shaw, R. A. Sicree, and P. Z. Zimmet, "Global estimates of the prevalence of diabetes for 2010 and 2030, " Diabetes Research and Clinical Practice, vol. 87, no. 1, pp. 4-14, 2010.
8. H. King, R. E. Aubert, and W. H. Herman, "Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections, " Diabetes Care, vol. 21, no. 9, pp. 1414-1431, 1998.
9. S. Murarka and M. R. Movahed, "Diabetic cardiomyopathy, " Journal of Cardiac Failure, vol. 16, no. 12, pp. 971-979, 2010.
10. A. Krishnamurthi, The Wealth of India-Raw Materials: Ph-Re, vol. 8, Publication and Information Directorate, Council of Scientific and Industrial Research, New Delhi, India, 1998.
11. S. L. Badole and L. Bodhankar, "Antihyperglycemic activity of Pongamia pinnata stem bark in diabetic mice, " Pharmaceutical Biology, vol. 46, no. 12, pp. 900-905, 2008.
12. S. L. Badole and S. L. Bodhankar, "Investigation of antihyperglycaemic activity of aqueous and petroleum ether extract of stem bark of Pongamia pinnata on serum glucose level in diabetic mice, " Journal of Ethnopharmacology, vol. 123, no. 1, pp. 115-120, 2009.
13. S. L. Badole and S. L. Bodhankar, "Concomitant administration of petroleum ether extract of the stem bark of Pongamia pinnata (L.) Pierre with synthetic oral hypoglycaemic drugs in alloxan-induced diabetic mice, " European Journal of Integrative Medicine, vol. 1, no. 2, pp. 73-79, 2009.
14. S. L. Badole and S. L. Bodhankar, "Antihyperglycaemic activity of cycloart-23-ene-3, 25-diol isolated from stem bark of Pongamia pinnata in alloxan induced diabetic mice, " Research Journal of Phytochemistry, vol. 3, no. 1, pp. 18-24, 2009.
15. S. L. Badole and S. L. Bodhankar, "Antidiabetic activity of cycloart-23-ene-3, 25-diol (B2) isolated from Pongamia pinnata (L. Pierre) in streptozotocin-nicotinamide induced diabetic mice, " European Journal of Pharmacology, vol. 632, no. 1-3, pp. 103-109, 2010.
16. S. L. Badole, P. P. Bagul, S. P. Mahamuni et al., "Oral L-glutamine increases active GLP-1 (7-36) amide secretion and improves glycemic control in stretpozotocin-nicotinamide induced diabetic rats, " Chemico-Biological Interactions, vol. 203, no. 2, pp. 530-541, 2013.
17. S. L. Badole, S. L. Bodhankar, and C. G. Raut, "Protective effect of cycloart-23-ene-3, 25-diol (B2) isolated from Pongamia pinnata L. Pierre on vital organs in streptozotocinnicotinamide induced diabetic mice, " Asian Pacific Journal of Tropical Biomedicine, vol. 1, supplement, no. 2, pp. S186-S190, 2011.
18. T. F. Slater and B. C. Sawyer, "The stimulatory effects of carbon tetrachloride and other halogenoalkanes on peroxidative reactions in rat liver fractions in vitro. General features of the systems used, " Biochemical Journal, vol. 123, no. 5, pp. 805-814, 1971.
19. M. S. Moron, J. W. Depierre, and B. Mannervik, "Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver, " Biochimica et Biophysica Acta, vol. 582, no. 1, pp. 67-78, 1979.
20. H. P. Misra and I. Fridovich, "Therole of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase, " The Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170-3175, 1972.
21. O. H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randell, "Protein measurement with the folin phenol reagent, " The Journal of biological chemistry, vol. 193, no. 1, pp. 265-275, 1951.
22. S. Xi, G. Zhou, X. Zhang, W. Zhang, L. Cai, and C. Zhao, "Protective effect of total aralosides of Aralia elata (Miq) Seem (TASAES) against diabetic cardiomyopathy in rats during the early stage, and possible mechanisms, " Experimental and Molecular Medicine, vol. 41, no. 8, pp. 538-547, 2009.
23. Y. Li, Y. Gu, Y. Song et al., "Cardiac functional analysis by electrocardiography, echocardiography and in situ hemodynamics in streptozotocin-induced diabetic mice, " Journal of Health Science, vol. 50, no. 4, pp. 356-365, 2004.
24. D. Qin, B. Huang, L. Deng et al., "Downregulation of K+ channel genes expression in type I diabetic cardiomyopathy, " Biochemical and Biophysical Research Communications, vol. 283, no. 3, pp. 549-553, 2001.
25. R. Wichi, C. Malfitano, K. Rosa et al., "Noninvasive and invasive evaluation of cardiac dysfunction in experimental diabetes in rodents, " Cardiovascular Diabetology, vol. 6, article 14, 8 pages, 2007.
26. O. Yamaguchi, Y. Higuchi, S. Hirotani et al., "Targeted deletion of apoptosis signal-regulating kinase 1 attenuates left ventricular remodeling, " Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 15883-15888, 2003.
27. G. R. Borges, M. de Oliveira, H. C. Salgado, and R. Fazan Jr., "Myocardial performance in conscious streptozotocin diabetic rats, " Cardiovascular Diabetology, vol. 5, article 26, 2006.
28. D. Sun, M. Shen, J. Li et al., "Cardioprotective effects of tanshinone IIApretreatment via kinin B2 receptor-Akt-GSK-3 dependent pathway in experimental diabetic cardiomyopathy, " Cardiovascular Diabetology, vol. 10, article 4, 2011.
29. E. Edet, M. Akpanabiatu, A. Eno, I. Umoh, and E. Itam, "Effect of Gongronema latifolium crude leaf extract on some cardiac enzymes of alloxan-induced diabetic rats, " African Journal of Biochemistry Research, vol. 3, pp. 366-369, 2009.
30. L. Cai and Y. J. Kang, "Oxidative stress and diabetic cardiomyopathy: a brief review, " Cardiovascular Toxicology, vol. 1, no. 3, pp. 181-193, 2001.
31. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, "Diabetes, oxidative stress, and antioxidants: a review, " Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24-38, 2003.
32. S. Moussa, "Oxidative stress in diabetes mellitus, " Romanian Journal of Biophysics, vol. 18, pp. 225-236, 2008.
33. L. Cai, J. Wang, Y. Li et al., "Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy, " Diabetes, vol. 54, no. 6, pp. 1829-1837, 2005.
34. E. E. Farmer and C. Davoine, "Reactive electrophile species, " Current Opinion in Plant Biology, vol. 10, no. 4, pp. 380-386, 2007.
35. D. Del Rio, A. J. Stewart, and N. Pellegrini, "A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress, "Nutrition, Metabolismand Cardiovascular Diseases, vol. 15, no. 4, pp. 316-328, 2005.
36. M. Hamblin, D. B. Friedman, S. Hill, R. M. Caprioli, H. M. Smith, and M. F. Hill, "Alterations in the diabetic myocardial proteome coupled with increased myocardial oxidative stress underlies diabetic cardiomyopathy, " Journal of Molecular and Cellular Cardiology, vol. 42, no. 4, pp. 884-895, 2007.
37. A. Akula, M. K. Kota, S. G. Gopisetty et al., "Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats, " Pharmacological Research, vol. 48, no. 5, pp. 429-435, 2003.